Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

References

• Feng D , Zeng Z , Liao F , et al. Analysis on factors influencing anxiety and depression of inpatients with diabetes mellitus type 2. Chin J Health Stat . 2010;27:129–132.
   Google Scholar
• DeFronzo RA , Ferrannini E , Groop L , et al. Type 2 diabetes mellitus. Nat Rev Dis Primers . 2015;1:15019. doi:10.1038/nrdp.2015.19 27189025
   PubMed Web of Science ®Google Scholar
• Fisher EB , Thorpe CT , Devellis BM , Devellis RF . Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ . 2007;33(6):1080–1103. doi:10.1177/0145721707309808 18057276
   PubMed Web of Science ®Google Scholar
• Tian L , Xuelian L , Lan Yutao QS . Depression level and relevant factors of the old patients with diabetes mellitus type 2. Chin J Gerontol . 2013;33:2115–2117.
   Google Scholar
• Xie J , Deng W . Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat . 2017;13:2681–2690. doi:10.2147/NDT.S116465 29123401
   PubMed Web of Science ®Google Scholar
• Inzucchi SE , Bergenstal RM , Buse JB , et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia . 2012;55(6):1577–1596. doi:10.1007/s00125-012-2534-0 22526604
   PubMed Web of Science ®Google Scholar
• Cusi K , Consoli A , Defronzo RA . Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab . 1996;81(11):4059–4067. doi:10.1210/jcem.81.11.8923861 8923861
   PubMed Web of Science ®Google Scholar
• Weiss R , Fernandez E , Liu Y , Strong R , Salmon AB . Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) . 2018;10(3):386–401. doi:10.18632/aging.v10i3 29579736
   PubMedGoogle Scholar
• Turner RC , Cull AC , Frighi V , et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA . 1999;281(21):2005–2012.10359389
   PubMed Web of Science ®Google Scholar
• Kim SA , Lam TG , Yook JI , Ahn SG . Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice. Aging (Albany NY) . 2018;10(9):2338–2355. doi:10.18632/aging.101549 30222592
   PubMedGoogle Scholar
• Nissen SE , Nicholls SJ , Wolski K , et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA . 2008;299(13):1561–1573. doi:10.1001/jama.299.13.1561 18378631
   PubMed Web of Science ®Google Scholar
• Culy CR , Jarvis B . Repaglinid. Drugs . 2001;61(11):1625–1660. doi:10.2165/00003495-200161110-00008 11577798
   PubMed Web of Science ®Google Scholar
• Li Y , Xu L , Shen J , et al. Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed type 2 diabetes mellitus. Diabetes Res Clin Pract . 2010;88(1):42–47. doi:10.1016/j.diabres.2009.12.017 20060192
   PubMed Web of Science ®Google Scholar
• Derosa G , Mugellini A , Ciccarelli L , Crescenzi G , Fogari R . Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors. Clin Ther . 2003;25(2):472–484.12749508
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetesd-2016 abridged for primary care providers. Diabetes Care . 2016;34(1):3–21.
   Google Scholar
• Kok JL , Williams A , Zhao L . Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review. Int J Nurs Stud . 2015;52(10):1625–1639. doi:10.1016/j.ijnurstu.pire3,j2015.05.012 26118440
   PubMed Web of Science ®Google Scholar
• Riley RD , Higgins JP , Deeks JJ . Interpretation of random effects meta-analyses. BMJ . 2011;342:d549. doi:10.1136/bmj.d549 21310794
   PubMed Web of Science ®Google Scholar
• Higgins JP , Thompson SG , Deeks JJ , Altman DG . Measuring inconsistency in meta-analyses. BMJ . 2003;327:557–560. doi:10.1136/bmj.327.7414.557 12958120
   PubMed Web of Science ®Google Scholar
• Sacks HS , Berrier J , Reitman D , Ancona-Berk V , Chalmers TC . Meta-analyses of randomized controlled trials. N Engl J Med . 1987;316:450–455. doi:10.1056/NEJM198702193160806 3807986
   PubMed Web of Science ®Google Scholar
• Yu D . Comparative analysis of the efficacy of glimepiride or repaglinide in combination with metformin in treating T2DM. Chin J Mod Drug Appl . 2010;4(11):101–102.
   Google Scholar
• Ren J , Minjuan G . Efficacy of glimepiride or repaglinide with metformin in treating Type 2 diabetes mellitus. J Clin Med Pract . 2006;12:87–88.
   Google Scholar
• Li J , Wang H , Wang L . Clinical observation and nursing intervention of glimepiride in the treatment of type 2 diabetes mellitus in the community. Haixia Med . 2012;24(7):180–181.
   Google Scholar
• Kong J . Repaglinide versus glimepiride treatment of type 2 diabetes mellitus. Pract Appl . 2016;20(3):307–308.
   Google Scholar
• Li Y . Observation on the therapeutic effect of repaglinide combined with metformin in the treatment of patients with type 2 diabetes mellitus. Chin Commun Doctors . 2016;32(13):41–42.
   Google Scholar
• Li Y , Zhu B , Liu Z . Clinical observation of the treatment of T2DM using glimepiride or repaglinide in combination with metformin. J Clin Exp Med . 2009;8(12):75–76.
   Google Scholar
• Wang H , Zhang B . Clinical observation of glimepiride or repaglinide in combination with metformin in treating type 2 diabetes. Chin Commun Doctors . 2011;13(274):45.
   Google Scholar
• Tian S . Clinical observation of repaglinide with metformin in treating type 2 diabetes. Chin J Clin Res . 2012;25(2):136–137.
   Google Scholar
• Cheng Z . Glimepiride and repaglinide together with dimethyldiguanide treat diabetes II. Zhejiang Da Xue Xue Bao Yi Xue Ban . 2006;30(5):490–491.
   Google Scholar
• Dimic D , Velojic GM , Antic S , Radenkovic S . Evaluation of the repaglinide efficacy in comparison to the glimepiride in the type 2 diabetes patients poorly regulated by the metmorfine adiminstratino. Bratisl Lek Listy . 2009;110(6):335–339.19634573
   PubMed Web of Science ®Google Scholar
• Zhao H . Therapeutic effect of different drugs combined with metformin on initial type 2 diabetes. Mod J Integr Trad Chin Western Med . 2012;21(25):2785–2787.
   Google Scholar
• Liu X , Yan L . A review of the efficacy and safety of glinides. Drugs Clinic . 2015;12(13):16–18.
   Google Scholar
• Wang Q , Ji H , Rong H , Sun H , Huang L . Effects of different insulin secretagogues on apoptosis of islet β cells. J Med Res . 2010;39(3):97–101.
   Google Scholar
• Wang Y , Xiujun L . Effect of metformin on islet β cell insulin resistance. West China Med J . 2009;24(5):1318–1319.
   Google Scholar
• Chen J-J , Xie J , Zeng L , Zhou C-J , Zheng P , Xie P . Urinary metabolite signature in bipolar disorder patients during depressive episode. Aging (Albany NY) . 2019;11(3):1008–1018. doi:10.18632/aging.101805 30721880
   PubMedGoogle Scholar
• Chen J , Bai SJ , Li W , et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl Psychiatry . 2018;8(1):192. doi:10.1038/s41398-018-0245-0 30232320
   PubMed Web of Science ®Google Scholar
• Hou L , Wei X , Zhuo Y , et al. GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age. Aging (Albany NY) . 2018;10(9):2252–2265. doi:10.18632/aging.101535 30178754
   PubMedGoogle Scholar